{"id":1038996,"date":"2012-03-15T23:27:28","date_gmt":"2012-03-15T23:27:28","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/bioinformatics-market-outlook-to-2015.php"},"modified":"2024-08-17T16:23:09","modified_gmt":"2024-08-17T20:23:09","slug":"bioinformatics-market-outlook-to-2015","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/bioinformatics-market-outlook-to-2015.php","title":{"rendered":"Bioinformatics Market Outlook to 2015"},"content":{"rendered":"<p><p>    NEW YORK, March 15, 2012 \/PRNewswire\/    --Reportlinker.com announces that a new market research    report is available in its catalogue:  <\/p>\n<p>    <a href=\"http:\/\/www.reportlinker.com\/p0795432\/Bioinformatics-Market-Outlook-to-2015.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=Genomics\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p0795432\/Bioinformatics-Market-Outlook-to-2015.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=Genomics<\/a>  <\/p>\n<p>    During the past decade, the bioinformatics market has    significantly evolved across the globe on back of rising    genomics industry. The increasing application of genomics in    biotech and pharmaceutical research and development has created    a huge commercial market for bioinformatics worldwide. As per    our latest research report's estimation, the global    bioinformatics market, which reached the mark of around US$ 3    Billion in 2010, will expand at a CAGR of around 25% during    2012-2015 as the declining cost of human genome sequencing and    increasing public and private sector investment will give a    significant boost to the industry.  <\/p>\n<p>    According to \"Bioinformatics Market Outlook to 2015\", the    content market that includes specialized and generalized    databases was the biggest segment of the global bioinformatics    industry in 2010, followed by analysis software & services    and IT infrastructure. As per our analysis, the software    segment is likely to exhibit strong performance in future,    improving its share in the overall market. On the other hand,    content\/database market will suffer the downturn due to the    increasing popularity of innovative analysis software. We have    also discussed in the report how the free databases would    impact the sales of the paid ones.  <\/p>\n<p>    Our report analyzed the wide application of bioinformatics in    genomics, proteomics and pharmacogenomics. A further in-depth    study of the market revealed that genome studies have    completely transformed cancer research in the past few years    and oncology has become the leading therapeutic area supported    by bioinformatics. We also observed that small firms in the    field are opting for outsourcing route to expand their    presence. The other key trends and drivers pushing the market    have also been elaborated in the comprehensive research study.  <\/p>\n<p>    The market has witnessed the launches of key bioinformatics    products and services in various areas, and we have evaluated    these on the basis of their companies and countries in our    report. The research includes country-level analysis and looks    into the recent developments that may impact the industry's    future performance in a significant manner. By providing a    brief profile of key market players like Accelrys and    Affymetrix and evaluating their recent activities in the study,    we have presented the industry's competitive landscape.    Overall, the report aims at providing an in-depth knowledge    about the global bioinformatics market to clients and    investors.1. Analyst View2. Research Methodology3. Key Industry    Trends and Drivers3.1 Increasing Bioinformatics R&D Efforts    by Players3.2 Strategic Collaborations Aimed at Enhancing    Innovations3.3 Financial Support by Governments Strengthening    Bioinformatics Research3.4 Oncology Research - Leading    Therapeutic Area Being Aided by Bioinformatics3.5 Small Firms    Enlarging Presence through Bioinformatics Outsourcing3.6 IT and    Internet Growth Boosting Usage of Bioinformatics Tools4. Market    Overview4.1 By Segment4.1.1 Analysis Software &    Services4.1.2 Content\/Database4.1.3 IT Infrastructure4.2 By    Application4.2.1 Genomics4.2.2 Proteomics4.2.3    Pharmacogenomics5. Prominent Country Profile5.1 US5.2 UK5.3    Japan5.4 India5.5 China5.6 South Korea5.7 Taiwan5.8    Singapore5.9 Australia6. Recently Commercialized Products and    Services7. Key Players7.1 Accelrys, Inc.7.2 Affymetrix, Inc.7.3    Compugen Ltd.7.4 IBM Life Sciences7.5 Kinexus  <\/p>\n<p>    List of Figures:  <\/p>\n<p>    Figure 4-1: Global - Cost of Genome Sequencing (US$), 1990 to    2015Figure 4-2: Global - Bioinformatics Market (Billion US$),    2010-2015Figure 4-3: Global - Bioinformatics Market by Segment    (%), 2010Figure 4-4: Global - Analysis Software & Services    Market (Million US$), 2010-2015Figure 4-5: Global - Content    Market (Million US$), 2010-2015Figure 4-6: Global - IT    Infrastructure Market (Million US$), 2010-2015Figure 4-7:    Global - Bioinformatics IT Infrastructure Market by Segment    (%), 2010Figure 4-8: Global - DNA Sequencing Market (Billion    US$), 2010-2015Figure 4-9: Global - Proteomics Market (Billion    US$), 2010-2015Figure 4-10: Global - Pharmacogenomics Market by    Segment (%), 2009Figure 5-1: UK - Bioinformatics Market    (Million US$), 2010-2015Figure 5-2: India - Bioinformatics    Market (Billion INR), 2010-2015Figure 5-3: South Korea -    Bioinformatics Market (Million US$), 2010-2015  <\/p>\n<p>    List of Tables:  <\/p>\n<p>    Table 4-1: Key Molecular Dynamics SoftwareTable 4-2: Key    Molecular Modeling SoftwareTable 4-3: Key Open Source    Bioinformatics SoftwareTable 4-4: Types of Generalized    DatabasesTable 4-5: Types of Specialized DatabasesTable 4-6:    Top Countries for High Content Analysis ResearchTable 4-7:    Growth in Key Bioinformatics Databases (Dec 2010 & Dec    2011)Table 4-8: Top Countries for DNA Sequence Analysis    ResearchTable 4-9: Key Genome Interpretation Databases and    ResourcesTable 4-10: Available Data Sources and Gene    Prioritization ToolsTable 4-11: Single Nucleotide Variants    Interpretation ToolsTable 4-12: Top Countries for Proteomics    ResearchTable 4-13: Mass Spectrometry E-ProgramsTable 4-14:    2-DE E-DatabasesTable 4-15: Key Pharmacogenomic DatabasesTable    4-16: Top Ten PharmGKB Gene, Drug, Disease and Pathway Pages    (2009)Table 5-1: Top Countries for Bioinformatics ResearchTable    6-1: Recently Commercialized Bioinformatics ProductsTable 6-2:    Recently Commercialized Bioinformatics Services  <\/p>\n<\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bioinformatics-market-outlook-2015-094600969.html\" title=\"Bioinformatics Market Outlook to 2015\" rel=\"noopener\">Bioinformatics Market Outlook to 2015<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEW YORK, March 15, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: <a href=\"http:\/\/www.reportlinker.com\/p0795432\/Bioinformatics-Market-Outlook-to-2015.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=Genomics\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p0795432\/Bioinformatics-Market-Outlook-to-2015.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=Genomics<\/a> During the past decade, the bioinformatics market has significantly evolved across the globe on back of rising genomics industry. The increasing application of genomics in biotech and pharmaceutical research and development has created a huge commercial market for bioinformatics worldwide <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/bioinformatics-market-outlook-to-2015.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246862],"tags":[],"class_list":["post-1038996","post","type-post","status-publish","format-standard","hentry","category-pharmacogenomics"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038996"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1038996"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038996\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1038996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1038996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1038996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}